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Abstract
Background: Shigella spp. are major cause of diarrhoeal disease in both developing and developed
countries. Shigella sonnei is the serogroup of Shigella most frequently responsible for sporadic and
epidemic enteritis in developed countries. In recent years the emergence and spread of S. sonnei
biotype g carrying class 2 integron have been frequently reported in many countries. Recently, S.
sonnei has been reported as the prevalent serogroup of Shigella in Iran.
The present study was carried out to investigate phenotypic and genetic characteristics of Shigella
sonnei isolates identified in the years 2002 and 2003 in Tehran, Iran.
Methods: Biotyping, drug susceptibility testing, pulsed field gel electrophoresis (PFGE) and analysis
of class 2 integrons have been carried out on 60 S. sonnei isolates, including 57 sporadic isolates
from paediatric cases of shigellosis occurring in 2002 and 2003, two sporadic isolates recovered in
1984 and the ATCC 9290 strain.
Results: Biotype g and resistance to streptomycin, sulfamethoxazole-trimethoprim and
tetracycline were exhibited by 54 of the 57 recent isolates. Of the 54 biotype g isolates, 28
exhibited a class 2 integron of 2161 bp, and 24 a class 2 integron of 1371 bp, respectively. Class 2
integrons were not detected in four isolates only, including the two endemic isolates recovered in
1984 and two strains from recent sporadic cases. PFGE divided the strains into eight pulsotypes
labeled A to H, three major pulsotypes – A to C – including the large majority of the recent
sporadic S. sonnei isolates. Pulsotypes A and C were the most prevalent groups, accounting for
41.6% and 35.0%, respectively, of the isolates under study.
Conclusion: The results suggest that biotype g, class 2 integron carrying S. sonnei are prevalent in
our geographic area. S. sonnei isolated in the years 2002 and 2003 could be attributed to a few
predominant clusters including, respectively, strains with pulsotypes B and C carrying a 2161 bp
class 2 integron, and those having pulsotype A and a 1371 bp class 2 integron. A few epidemic
clones are responsible for the apparently endemic occurrence of shigellosis in Tehran, Iran.
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Infections caused by Shigella species are a major cause of
diarrhoeal disease in both developing and developed
countries. Globally, it is estimated that shigellosis causes
about 1,100,000 deaths per year, two-thirds of the
patients being children under 5 years of age [1,2].
Development and spread of multidrug resistance is
becoming a serious threat to Public Health worldwide
since the early 1960s [3]. Mobile genetic elements, such as
plasmids, transposons, genomic islands and integrons,
disseminating via horizontal transfer are exponentially
amplifying the problem [4]. In particular, the role of inte-
grons in the dissemination of multidrug resistance in
Gram-negative bacteria is well-established [5], and their
carriage by several members of the family Enterobacte-
riaceae has been reported [6].
Recently, several reports have shown the successful emer-
gence and spread in different countries of S. sonnei biotype
g carrying a class 2 integron [4,7-12]. Pulsed Field Gel
Electrophoresis (PFGE) analysis has proved that related
groups of isolates may have circulating in recent years in
different European countries [8]. Emergence and selective
pressure by use of some antimicrobial agents or, alterna-
tively, international trade are under debate as possible
epidemiological mechanisms of the successful dissemina-
tion of this organism [13].
Shigellosis is one of the major causes of morbidity in chil-
dren with diarrhea in Iran, but reports about prevalence of
serogroups and molecular epidemiological features are
limited. In two previous studies, S. flexneri has been
reported as the most prevalent species in this country in
the years 1984–'85 and 2001–'02 [14,15]. Similar pat-
terns of serogroup prevalence have been detected in some
neighboring countries. Indeed, S. flexneri, as the most fre-
quent serogroup, accounted for 44.0%, 58.0%, and
65.0%, respectively, of shigellosis cases in Saudi Arabia
[16], Pakistan [17] and Jordan [18]. In a subsequent
investigation conducted in 2003, however, shifting of spe-
cies distribution of Shigella appeared to occur in Tehran,
Iran, where the proportion of S. sonnei isolates was 58.9
%, while that of S. flexneri 36.4% [19]. More recently, Far-
shad et al. (2006) has identified S. sonnei as the most prev-
alent Shigella species in Shiraz, Iran [20].
The present study was therefore undertaken to describe
phenotypic and genetic characteristics of S. sonnei isolates
identified in the years 2002–2003 in Tehran, Iran. Preva-
lence of biotypes, drug susceptibility patterns, pulsotypes
and carriage of class 2 integrons was investigated with spe-
cial attention to obtain an interpretative key of the appar-




In the years 2002 and 2003, a total of 178 isolates of S.
sonnei have been isolated from enteritis cases in children
at five hospitals in Tehran, Iran. A random sample of 57
isolates was selected for the investigation. Three further
strains were added: the S. sonnei strain ATCC 9290 and
two apparently sporadic strains isolated in Tehran, Iran, in
1984.
All strains had been identified at a genus level by conven-
tional methods by previously described procedures [21]
while agglutination with specific antiserum from MAST
Group LTD (Mast House, Derby Road, Bootle, Mersey-
side, L20 1EA, UK) was used to identify the species.
Biotyping was performed by the method of Nastasi et al.
[21]. Antimicrobial susceptibility test was performed by
the disk diffusion method according to the guidelines of
the National Committee for Clinical Laboratory Stand-
ards [22]. The following antimicrobial agents were tested:
ampicillin, AMP (10 μg); ceftriaxone, CRO (30 μg); kan-
amycin, K (30 μg); streptomycin, STR (10 μg); tetracy-
cline, TET (30 μg); ciprofloxacin, CP (5 μg); nalidixic acid,
NA (30 μg); chloramphenicol, C (30 μg); and sulfameth-
oxazole-trimethoprim, SXT (1.25/23.75 μg). Escherichia
coli ATCC 25922 was used as a quality control strain.
Pulsed Field Gel Electrophoresis (PFGE) analysis
All S. sonnei isolates were analyzed by PFGE with the
restriction enzyme XbaI (Promega, Madison, WI, USA)
under standardized conditions [23]. The Salmonella sero-
type Braenderup strain H9812 restricted with XbaI was
used as molecular weight standard. Strain H9812 was
kindly provided by the National Reference Centre for
Enteric Pathogens at Istituto Superiore di Sanità, Rome,
Italy.
PFGE patterns were initially visually assessed and inter-
preted by using the criteria established by Tenover et al.
[24]. Computer-assisted analysis of the PFGE banding
patterns was then performed with the Taxotron software
(Taxolab, Institut Pasteur, Paris, France). Genetic dis-
tances were calculated using the Unweighted Pair Group
Method using arithmetic Averages (UPGMA). Only bands
whose molecular weight exceeded 90 Kbp were consid-
ered and the calculated error was set at 10% for low
molecular weight and progressively decreased to 5% for
the highest weights (1,000 Kbp).
Class 2 integron analysis
To detect the class 2 integrons, primer pair hep74 (5'-
CGGGATCCCGGACGGCATGCAC GATTTGTA-3') and
hep51 (5'-GATGCCATCGCAAGTACGAG-3') was used
under conditions described previously [8]. AmplifiedPage 2 of 7
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cloning Kit (Invitrogen Life Technology, Italy) in invα F'
cells. The cloned products were sequenced by fluorescent
dye-labeled dideoxynucleotides and a 373 automatic
DNA sequencer (Perkin-Elmer, Foster City, CA), using the
universal primers M13fw and M13rev for the first 1400 bp
and the primer ss1, 5'-AAGTGGCAGCAACGGATTCG-3',
to complete the sequence. The resulting DNA sequence
was analyzed by use of the BLAST search program 2.0
within the QBLAST system at the National Center for Bio-
technology Information site.
PFGE-CeuI and hybridization
To establish if the class 2 integrons were located on the
chromosome, the restriction enzyme CeuI was used to
generate a pulsed-field gel electrophoresis (PFGE) profile
to be hybridized with the int2 sequence. CeuI is a rare-cut-
ting enzyme, which produces very large restriction frag-
ments. The preparation of genomic DNA of S. sonnei
strains was performed according to the above protocol.
Then, DNA restriction was done with 10U CeuI enzyme
(New England Biolabs, Beverly, MA, US) at 37°C for 3 h
and DNA macrorestriction fragments were resolved on
0.7% agarose gel (Pulsed Field Certified, Bio-Rad, Her-
cules, CA, US) prepared in 0.5X TBE buffer (50 mM Tris,
50 mM boric acid, 0.5 mM EDTA). Lambda ladder concat-
amers (New England Biolabs) were used as molecular
marker. The gel was run on a CHEF-DRII system (Bio-Rad
Laboratories) under the conditions described by Liu et al.
[25]. The gel, after staining for 10 min in ethidium bro-
mide solution (0.4 μg/ml) and destaining in distilled
water for 20 min, was visualised under UV light and pho-
tographed.
Restricted fragments were transferred onto positively
charged nylon membranes (Roche Diagnostics, Monza,
Italy) by standard methods [25]. Southern blot hybridiza-
tion was carried out under high-stringency conditions
[26] using specific int2 and 16sRNA probes, obtained
amplifying the internal part of the respective genes with
the following primers: int2, ssfw 5'-TTTCAGGTGGT-
GGGGAGATA-3' and ssrv 5'-TTGGTACAAAAGGCGT-
GACA-3'; 16sRNA, S16fw 5'-CAGCCACAC-
TGGAACTGAGA-3' and S16rev 5'-GTTAGCCGGTG-
CTTCTTCTG-3'. Probes were labelled by the "PCR DIG
labelling" kit (Roche Diagnostics).
Results
Fifty-four of the 57 isolates of S. sonnei identified in the
period 2002–'03 and selected for the study were attrib-
uted to biotype g and three only to biotype a. Both strains
isolated in 1984 were biotype g (Additional file 1).
Additional file 1 summarizes the antimicrobial resistance
phenotypes of the isolates under study. Fifty-four S. sonnei
isolates obtained during the years 2002 and 2003 were
resistant to streptomycin, sulfamethoxazole-trimetho-
prim and tetracycline. Additional resistances to nalidixic
acid, ampicillin or kanamycin were carried by four, five
and two isolates, respectively. Two further isolates showed
ampicillin resistance associated to nalidixic acid or kan-
amycin, respectively. No isolates were resistant to ceftriax-
one, ciprofloxacin, or chloramphenicol.
Three major clusters of S. sonnei were identified by XbaI-
PFGE among the sample of isolates recovered in Tehran,
Iran, in 2002 and 2003 (Figure 1): PFGE type A (n = 25
isolates), PFGE type B (n = 7 isolates) and PFGE type C (n
= 21 isolates). Three subtypes – a to c – were included into
PFGE type A, subtype a including 18 of the 25 strains. Two
subtypes, a and b, grouping five and two isolates, respec-
tively, were observed among type B strains. Type C con-
tained three subtypes, a to c, but subtype a included 15 of
21 isolates. The two isolates identified in 1984 were type
E.
Two different class 2 integron structures were identified
within the isolates under study. Twenty-eight (49.1%) of
the 57 isolates shared a 2161 bp class 2 integron, identi-
fied by DNA sequencing as containing four open reading
frames, namely dhfrI, satI, aadA and orfX (99% of homol-
ogy with respect to the class 2 integron described by Pan
JC et al, 2006). The second smaller integron of 1371 bp
containing only two genes within the cassettes, dhfrI and
satI, was detected in 24 strains (42.1%). Alignments of the
deduced amino acid sequences revealed two sequence
substitutions in both gene cassettes, dhfrI and satI. The
sequence of the class 2 integron of 1371 bp has been sub-
mitted to GenBank (accession number AM745943).
Class 2 integrons were not detected in two strains from
sporadic cases occurring in 2003 and in the two strains
isolated in 1984. Probing using specific int2 and 16sRNA
probes confirmed the chromosomal location of both
types of class 2 integrons (see additional file 2).
All isolates belonging to PFGE types B and C proved to
possess the 2161 bp class 2 integron. Moreover, a closest
association was found between pulsotype A and the 1371
bp class 2 integron: indeed, all, but one, PFGE type A iso-
lates were found to carry the smaller class 2 integron
(Additional file 1 and Figure 1).
Discussion
Our study was undertaken to perform a baseline assess-
ment of the epidemiologic features characterizing the
endemic circulation of S. sonnei in Iran.
Biotype g included all, but three, recent isolates of S. son-
nei. Emergence of biotype g or rhamnose negative strainsPage 3 of 7
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ferent continents in association with the characteristic
resistance pattern streptomycin-trimethoprim frequently
associated to tetracycline [4,8,11]. Moreover, antimicro-
bial susceptibility testing of the Iranian isolates showed a
highest prevalence of a consistent resistance profile,
accordingly to the reports from a number of countries
[3,6,28-31]. These antibacterial drugs are commonly used
worldwide in the treatment of dysentery. No resistance
was observed to ciprofloxacin, ceftriaxone, and chloram-
phenicol, probably because of their very infrequent use as
alternative therapeutic regimens in our geographic area.
Selective pressure by indiscriminate use of antibiotics and
mechanisms of horizontal gene transfer have undoubt-
edly contributed to the emergence and diffusion of multi-
resistance in Shigella [6].
Although other mechanisms are possible, resistance to
streptomycin and trimethoprim seems to be attributable
to expression of genes contained in class 2 integrons.
These structures have proved to be highly prevalent within
isolates of Shigella spp. from a number of countries
[4,6,8,10,11,14]. Their gene array, generally including the
open reading frames dhfrI, sat and aad, is rather stable,
because of the presence of a defective integrase, but some
different structures have been very infrequently found in
sporadic isolates of S. sonnei [3,8,32]. Our paper firstly
describes the simultaneous circulation at approximately
similar frequencies (49.1% vs. 42.1%) in an apparently
endemic context of two groups of strains carrying, respec-
tively, a class 2 integron of 2161 bp and a shorter inte-
gron, not containing the aad gene cassette sequence. No
specific association was apparent with the resistance pat-
tern.
When considering results obtained by PFGE, a first
impressive feature is the limited genetic heterogeneity of
the isolates under study, along with their clustering in a
few predominant PFGE types. These findings could sug-
gest that what is apparent as an endemic circulation of S.
sonnei in Tehran, Iran, is more likely to be interpreted as
an oligo-clonal epidemic. The paucity of types for a path-
ogen which has only humans as a significant reservoir of
infection, might derive from few sources of infection in a
context of epidemiological transition that, along with the
recent switching of predominant serogroup from flexneri
to sonnei, could suggest increasingly effective sanitary con-
ditions in Tehran, Iran. On the other hand, success of S.
sonnei is warranted also in developed countries by low
infectious minimal dose, high secondary attack rates and,
in comparison with the other serogroups, a better capabil-
ity to survive to stressing environmental conditions and
exploit alternative and more complex infectious routes,
such as food vehicles [33-35].
When considering the association of phenotypic and
genetic properties of multidrug resistance, our findings
reinforce the previous considerations and suggest the
involvement of our geographic area within an epidemio-
logical global picture of emergence and/or dissemination
of a limited number of well defined multiresistant clones
of S. sonnei. The question whether a multicentric emer-
gence under analogous selective factors of similar particu-
larly "fit" organisms or, alternatively, a dissemination
driven by the international trade of human and food
related resources were the most scientifically sound mech-
anism, arises with special evidence, when considering the
geographic scale of the phenomenon.
Molecular epidemiology provides a crucial contribution
to accurately interpret epidemiological evolution of infec-
tious diseases in communities, when screening by pheno-
typic methods, such as biotyping or drug resistance
pattern analysis, is seriously hindered by the homogeneity
of circulating strains.
Conclusion
The results suggest that biotype g, class 2 integron carrying
S. sonnei are prevalent in our geographic area. S. sonnei iso-
lated in the years 2002 and 2003 could be attributed to a
few predominant clusters including, respectively, strains
with pulsotypes B and C carrying a 2161 bp class 2 inte-
gron, and those having pulsotype A and a 1371 bp class 2
integron. A few epidemic clones are responsible for the
apparently endemic occurrence of shigellosis in Tehran,
Iran.
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